Related Experiment Video

Updated: Mar 31, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

3.0K

Bioinformatics prioritization of SNPs perturbing microRNA regulation of hematological malignancy-implicated genes

Hamid Ghaedi1, Milad Bastami1, Davood Zare-Abdollahi1

  • 1Medical Genetics Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Genomics
|November 2, 2015
PubMed

Insights

Genetic variations in microRNAs (miRNAs) and their targets are linked to blood cancers. This study identifies single nucleotide polymorphisms (SNPs) in miRNA target sites, crucial for understanding hematological malignancies.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • MicroRNAs (miRNAs) are critical regulators of gene expression, and their dysregulation is implicated in cancer.
  • Genetic variations, specifically single nucleotide polymorphisms (SNPs), within the miRNA regulome can disrupt miRNA-mRNA interactions.
  • SNPs in miRNA target sites are associated with hematological malignancies, but a comprehensive catalog is missing.

Purpose of the Study:

  • To systematically identify and characterize SNPs within miRNA target sites of genes relevant to hematopoiesis and hematological malignancies.
  • To provide a prioritized list of potentially disruptive SNPs for future functional studies.

Main Methods:

  • Bioinformatic analysis of miRNA target sites and associated genetic variations.
  • Systematic identification and characterization of SNPs within these regulatory regions.

Main Results:

  • A catalog of SNPs within miRNA target sites relevant to hematopoiesis and hematological malignancies was compiled.
  • A prioritized list of potentially disruptive SNPs was generated.

Conclusions:

  • The study provides a valuable resource for researchers investigating the role of target site SNPs in hematological malignancies.
  • Further functional studies are needed to determine the significance of these identified SNPs in disease pathogenesis.
Keywords:
Hematological malignancyLeukemiaMicroRNASingle nucleotide polymorphism

More Related Videos

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

9.0K
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
109